Spondyloarthritis & psoriatic arthritis

Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study

Ann Rheum DisPublished Cross-sectional study

Authors' conclusion

In our construct validity analysis, all disease activity instruments assessing peripheral arthritis had a good performance as reflected in the correlations with external constructs and the known-group discrimination. The highest discriminatory capacity to distinguish between 'active/inactive disease' was observed for composite scores, including joint counts, like DAS28 and DAPSA.

Study context

Population
Patients with a diagnosis of axSpA, pSpA or psoriatic arthritis (PsA) in the ASAS-PerSpA studymean age 45 [SD, 14] years, 61% males
Participants
4,121 patients
Exposure
Disease activity instruments assessing peripheral arthritis in spondyloarthritis (SpA)
Outcome
Construct validity, including known-group discrimination (active/inactive disease by PGA [≥5/<5] and SJC [≥1/0 and ≥2/<2]), analysed with SMDs
Methodological detailsanalysis of the ASAS-PerSpA study, construct validity analysis
  • Analysis of the ASAS-PerSpA study
  • Construct validity analysis

Main finding

As reported in the abstract

  • Correlations with external constructs (BASFI, ASAS Health Index, EQ-5D): all instruments performed excellently (100% hypotheses confirmed)
  • Known-group discrimination: all disease activity measures except C-reactive protein (CRP) presented standardised mean differences (SMDs) ≥ 0.8 (good discrimination)
  • Higher SMDs for DAS28 followed by DAPSA
  • Across all Patient Global Assessment (PGA) and Swollen Joint Count (SJC) combinations, better performance for composite scores including joint counts

Observational data: associations, not effects.

Further findings

Known-group discrimination by disease phenotype

Results similar across disease phenotypes

Original publication

Evaluation of instruments assessing peripheral arthritis in spondyloarthritis: an analysis of the ASAS-PerSpA study. Ann Rheum Dis. Published 17 March 2025. doi:10.1016/j.ard.2025.02.011

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.